Related by context. Frequent words. (Click for all words.) 68 commercializing therapeutic 67 Pivotal Phase III 66 Aradigm Corporation 66 Onalta 65 Kuvan R 65 Application MAA 65 Oscient Pharmaceuticals Corporation 65 pseudobulbar affect PBA 65 Application BLA 65 Celsion Corporation 65 Presents Positive 65 Rhucin ® 64 refractory chronic lymphocytic 64 Completes Enrollment 64 Cetrorelix 64 phase IIb clinical 64 forodesine 64 NASDAQ OSIR 64 Barrier Therapeutics Inc. 63 ImmuneRegen BioSciences Inc. 63 Nasdaq VRTX 63 NASDAQ CRXL 63 NASDAQ LGND 63 ZALBIN 63 non alcoholic steatohepatitis 63 Phase III Clinical Trial 63 Genaera Corporation 63 C1 esterase inhibitor 63 Orphan Drug status 63 R sorafenib tablets 63 Entereg R 63 Clostridium difficile associated 62 FDA Accepts 62 Idera Pharmaceuticals 62 diabetic macular edema DME 62 ATryn ® 62 Nasdaq REGN 62 ALN TTR# 62 Inc. Nasdaq IMGN 62 Fibrocell Science Inc. 62 topical anti infective 62 DOR BioPharma Inc. 62 Chemokine Therapeutics 62 Transcept Pharmaceuticals 62 Nasdaq ALTH 62 ThermoDox R 62 Microplasmin 62 BioSpecifics Technologies Corp. 62 VALSTAR 62 TRANSDUR Sufentanil 62 Shigamabs ® 62 NovaBay Pharmaceuticals Inc. 62 Patient Enrollment 62 Veronate 62 Advancing Drugs 62 Pivotal Trial 62 subcutaneous formulation 62 Fibrillex TM 62 novel antibody therapeutics 62 Aloxi R 61 SILENOR TM 61 Cerus Corporation 61 Diabetic Macular Edema 61 BioSilicon TM 61 ecallantide 61 Group NV Pharming 61 REVLIMID R 61 post herpetic neuralgia PHN 61 hereditary angioedema HAE 61 Hypoactive Sexual Desire Disorder 61 Anika Therapeutics Inc. 61 Omigard 61 orphan medicinal product 61 ZFP Therapeutic 61 phenylketonuria PKU developed 61 BioMarin develops 61 Factor VIIa 61 Orphan Drug Status 61 FavId 61 Nasdaq BDSI 61 Initiate Phase 61 Epratuzumab 61 NASDAQ DYAX 61 Marketing Authorization Application 61 Initiates Phase 61 carcinoid syndrome 61 immuno inflammatory diseases 61 Surgical Adhesive 61 Pirfenidone 61 ATL# [001] 61 Novelos Therapeutics Inc. 61 immunological diseases 60 MOZOBIL 60 Pivotal Study 60 Rebif ® 60 Crucell NV Euronext 60 Drug Candidate 60 Mipomersen 60 Lipid Sciences Inc. 60 Nasdaq ENZN 60 talactoferrin